International Pharmaceutical Abstracts: American Society of Hospital Pharmacists, Washington, D. C.
9.
Index Medicus: National Library of Medicine, U. S. Department of Health, Education and Welfare.
10.
RaneA., and SjoqvistF.: Drug Metabolism in the Human Fetus and Newborn Infant, Pediat. Clin. N. Amer.19: 37 (Feb.) 1972. (S)
11.
VestM. F., and SalzbergR.: Conjugation Reactions in the Newborn Infant: The Metabolism of Para-Aminobenzoic Acid, Arch. Dis. Childhood40: 97 (Feb.) 1965.
12.
GrossmanE. R.: Tetracycline and Permanent Teeth: The Relation Between Dose and Tooth Color, Pediat.47: 567 (Mar. 3) 1971.
13.
WatsonE. H., and LowreyG. H.: Growth and Development of Children, ed. 5, Year Book Publishers, Chicago, Ill., 1967, p. 397.
14.
KleinD. F., and DavisJ. M.: Diagnosis and Drug Treatment of Psychiatric Disorders, Williams and Wilkins, Co., Baltimore, Md., 1969, p. 420.
15.
GoodmanL. S., and GilmanA.: The Pharmacological Basis of Therapeutics, 4th ed., MacMillan Co., New York, N. Y., 1970.
16.
SternL.: Drug Interactions - Part II: Drugs, The Newborn Infant, and the Binding of Bilirubin to Albumin, Pediat.49: 916 (June) 1972.
17.
SchiffD.: Fixed Drug Combinations and the Displacement of Bilirubin from Albumin, Pediat.48: 139 (July) 1971.
18.
CohnG. A.: Pseudotumor Cerebri in Children Secondary to Administration of Adrenal Steroids, J. Neurosurg.20: 784 (Sept.) 1963.
19.
DeesS. C., and McKayH. W.Jr.: Occurrence of Pseudotumor Cerebri (Benign Intracranial Hypertension) During Treatment of Children With Asthma by Adrenal Steroids - Report of Three Cases, Pediat.23: 1143 (June) 1959.
20.
BakerL.: Diazoxide Treatment of Idiopathic Hypoglycemia of Infancy, J. Pediat.71: 494 (Oct.) 1967.
21.
PullenH.: Hypersensitivity Reactions to Antibacterial Drugs in Infectious Mononucleosis, Lancet2: 1176 (Dec. 2) 1967.
22.
PatelB. M.: Skin Rash With Infectious Mononucleosis and Ampicillin, Pediat.40: 910 (Nov.) 1967.
23.
WearyP.E.: Eruptions from Ampicillin in Patients With Infectious Mononucleosis, Arch. Dermatol.101: 86 (Jan.) 1970.
24.
CoskeyR. J., and PaulL.: Ampicillin Sensitivity in Infectious Mononucleosis, Arch. Dermatol.100: 717 (Dec.) 1969.
25.
SpeckW. T.: High Frequency of Ampicillin Rashes in Infectious Mononucleosis - Clinical Implications and Case Report, Clin. Pediat.10: 59 (Jan.) 1971.
PlainterH. A.: Precocious Pubescense - Iatrogenic, N. E. J. Med.270: 141 (Jan. 16) 1964.
28.
FischerD. A., and PantosT. C.: Methandrostenolone Therapy in Children With Growth Retardation, J. Amer. Med. Ass.185: 410 (Aug. 3) 1963.
29.
FossG. L.: The Influence of Androgen Treatment on Ultimate Height in Males, Arch. Dis. Childhood40: 66 (Feb.) 1965.
30.
FischR.O.: Methemoglobinemia in a Hospital Nursery, J. Amer. Med. Ass.185: 760 (Sept. 7) 1963.
31.
RossJ. D., and CiccarelliR. F.: Acquired Methemoglobinemia Due to Acetophenetidin: Report of a Case in a Small Infant, N. E. J. Med.266: 1202 (June 7) 1962.
32.
GreenblattJ.: Hyperthermia Due to Hypersensitivity to Methantheline Bromide (Banthine), Amer. J. Dis. Child.88: 25 (July) 1954.
33.
LevyH., and ZweiflerB. M.: The Use of Banthine Bromide in Infantile Colic and Vomiting, J. Pediat.40: 570 (May) 1952.
GoldbloomR. B., and GoldbloomA.: Boric Acid Poisoning: Report of 4 Cases and Review of 109 Cases from the World Literature, J. Pediat.43: 631 (Dec.) 1953.
KelseyW. M., and ScharylM.: Fatal Hepatitis Probably Due to Indomethacin, J. Amer. Med. Ass.199: 586 (Feb. 20) 1967.
55.
JacobsJ. C.: Sudden Death in Arthritic Children Receiving Large Doses of Indomethacin, J. Amer. Med. Ass.199: 162 (Mar. 20) 1967.
56.
BoreusK. O., and SundstromB.: Intracranial Hypertension in a Child During Treatment With Nalidixic Acid, Brit. Med. J.2: 744 (June 17) 1967.
57.
AndersonE.E.: Childhood Complications of Nalidixic Acid, J. Amer. Med. Ass.216: 1023 (May 10) 1971.
58.
WalkerS.H.: Nalidixic Acid in Childhood Urinary Tract Infection: Clinical and Laboratory Experience With Fifty Patients, Clin. Pediat.5: 718 (Dec.) 1966.
59.
LokietzH.: Studies on the Effect of Novobiocin on Glucuronyl Transferase, Pediat.32: 47 (July) 1963.
60.
LevyG., and ErtelI. J.: Effect of Bilirubin on Drug Conjugations in Children, Pediat.47: 811 (May) 1971.
61.
SutherlandJ. M., and KellerW. H.: Novobiocin and Neonatal Hyperbilirubinemia, Amer. J. Dis. Child.101: 447 (Apr.) 1961.
62.
ArandaJ.V.: Arterial Oxygen Tension and Retinal Vasoconstriction in Newborn Infants, Amer. J. Dis. Child122: 189 (Sep.) 1971.
63.
NewellF., and PatzA.: The Ophthalmologist in the Premature Nursery, Amer. J. Ophthalmol.66: 969 (Nov.) 1968.
64.
KalinaR. E.: Ophthalmic Examination of Children of Low Birth Weight, Amer. J. Ophthalmol.67: 134 (Jan.) 1969.
65.
NorthwayW.H.: Pulmonary Disease Following Respiratory Therapy of Hyaline Membrane Disease: Bronchopulmonary Dysplasia, N. E. J. Med.276: 357 (Feb. 16) 1967.
66.
AndersonW. R., and StricklandM. B.: Pulmonary Complication of Oxygen Therapy in the Neonate: Postmortem Study of Bronchopulmonary Dysplasia With Emphasis on Fibroproliferative Obliterative Bronchitis and Bronchiolitis, Arch. Pathol.91: 506 (June) 1971.
67.
SternL.: Negative Pressure Artificial Respiration: Use in Treatment of Respiratory Failure of the Newborn, Can. Med. Ass. J.102: 595 (Mar. 28) 1970.
68.
AydF. J.: A Survey of Drug-Induced Extrapyramidal Reactions, J. Amer. Med. Ass.175: 1054 (Mar. 25) 1961.
69.
BerkB. Z.: Reaction to Prochlorperazine (Letter to the Editor), Lancet1: 776 (Apr. 12) 1969.
70.
ClevelandW. W., and SmithG. F.: Complications Following the Use of Prochlorperazine (Compazine) as an Antiemetic, Amer. J. Dis. Child.96: 284 (Sept.) 1958.
71.
SucklingP. V.: Toxic Effects of Phenothiazine Derivatives Given for Vomiting in Children, S. Afr. Med. J.40: 1073 (Dec. 10) 1966.
72.
RyanJ.F.: Myoglobinemia After a Single Dose of Succinylcholine. N. E. J Med.285: 824 (Oct. 7) 1971.
73.
TammistoT., and AiraksinenM. M.: Suxamethonium-Induced Myoglobinemia (Correspondence), Brit. J. Anaesth.37: 464 (June) 1965.
74.
TammistoT.: Increase of Creatine Kinase Activity in Serum as Sign of Muscular Injury Caused by Intermittently Administered Suxamethonium During Halothane Anaesthesia, Brit. J. Anaesth.38: 510 (July) 1966.
75.
TammistoT.: The Inhibitory Effect of D-Tubocurarine on the Release of Serum-Creatine-Kinase Activity Produced by Intermittent Suxamethonium Administration During Halothane Anaesthesia, Acta. Anaesthesiol. Scand.11: 333
76.
SilvermanW.A.: A Difference in Mortality Rate and Incidence of Kernicterus Among Premature Infants Allotted to two Prophylactic Antibacterial Regimens, Pediat.4: 614 (Oct.) 1956.
77.
ThalerM. M., and SchmidR.: Drugs and Bilirubin, Pediat.47: 807 (May) 1971.
78.
OdellG. B.: The Dissociation of Bilirubin from Albumin and its Clinical Implications, J. Pediat.55: 268 (Sept.) 1959.
79.
ConchieJ.M.: The Incidence of Staining of Permanent Teeth by the Tetracyclines, Can. Med. Ass. J.103: 351 (Aug. 15) 1970.
80.
BrearleyL.J.: Tetracycline-Induced Tooth Changes: Part I - Prevalence in School Children. Med. J. Aust.2: 653 (Oct. 19) 1968.
81.
BrearleyL. J., and StoreyE.: Tetracycline-Induced Tooth Changes: Part 2 - Prevalence, Localization and Nature of Staining in Extracted Deciduous Teeth, Med. J. Aust.2: 714 (Oct. 26) 1968.
82.
MartinN. D., and BarnardP. D.: The Prevalence of Tetracycline Staining in Erupted Teeth, Med. J. Aust.1: 1286 (June 21) 1969.
83.
BakerK. L., and StoreyE.: Tetracycline-Induced Tooth Changes: Part 3 - Incidence in Extracted First Permanent Molar Teeth, Med. J. Aust.1: 109 (Jan. 17) 1970.
84.
AnthonyJ. R.: Effect on Deciduous and Permanent Teeth of Tetracycline Deposition in Utero, Postgrad. Med.48: 165 (Oct.) 1970.
85.
FieldsJ. P.: Bulging Fontanel: A Complication of Tetracycline Therapy in Infants, J. Pediat.58: 74 (Jan.) 1961.
86.
OpferK.: The Bulging Fontanelle (Letters to the Editor), Lancet1: 116 (Jan. 12) 1963.
87.
Koch-WeserJ., and GilmoreE. B.: Benign Intracranial Hypertension in Adult After Tetracycline Therapy, J. Amer. Med. Ass.200: 345 (Apr. 24) 1967.
88.
FinkelM. J.: Vitamin K and Vitamin K Analogues, Clin. Pharmacol. Ther.2: 794 (Nov.-Dec.) 1961.
89.
AllisonA. C.: Danger of Vitamin K to Newborn, Lancet1: 669 (Sept. 24) 1955.
90.
LauranceB.: Danger of Vitamin K Analogues to Newborn, Lancet1: 819 (Oct. 16) 1955.